On Tuesday, Moderna announced promising results from the Phase 1 study of its vaccine candidate, called mRNA-1273. The study, published in The New England Journal of Medicine showed that all 45 volunteers who received two vaccine doses developed immune responses that were stronger than in patients who have recovered from COVID-19. “These positive Phase 1 […]
New and improved grant programs, aimed at providing economic support to Utah businesses impacted by COVID-19, are being finalized under the Governor’s Office of Economic Development (GOED). These programs, a result of legislation, HB 5010, which passed the state legislature during a June special session, include a revamped Commercial Rental Assistance Program (ComRent), making it […]
BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking. “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]
This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]
Last month, Johnson & Johnson (J&J) announced that its Phase 1/2a in-human clinical trial of its potential COVID-19 vaccine was expected to begin in July – instead of September as initially scheduled. On Thursday, as reported by Fierce Pharma, J&J chief scientific officer Paul Stoffels confirmed the accelerated timeline, saying that the company has seen […]
U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for two COVID-19 vaccine candidates – BNT162b1 and BNT162b2 – part of the companies’ “Project Lightspeed” program. The designation was issued based on promising preliminary data from Phase 1/2 clinical studies. The FDA’s Fast Track designation is intended […]
The MedTech Conference is proud to bring you unparalleled programming opportunities every year, and this year is no exception. We’re sharing just a few of our sessions and networking opportunities that will be offered virtually in 2020. See what’s in store for this year and make plans to participate! Learn more here. […]
The Johnson & Johnson Innovation (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC’s, Angels and other investment entities. Maha Katabi and Sarah Bhagat from Sofinnova will present an overview of the fund, it’s investment strategy, primary areas of interest, and a few investment […]
Outsourcing isn’t a trend in the life sciences – it’s the new way of doing business. Join MasterControl Executive Vice President of Product, Matt Lowe, in an exclusive webinar on July 15 as he discusses the challenges posed by modern business ecosystems and the criticality of extensible and flexible quality management systems. Lowe will examine […]
Today innovators across the Rocky Mountain Southwest Region are pioneering new ways to : Prevent disease and improve health. Provide more timely and accurate diagnostics Personalize therapies so that the right patient gets the right treatments at the right time and has the best possible outcome Engineer medical devices that improve the quality of life […]
Join youngStartup Ventures this August for the virtual 2020 Venture Summit. You can participate in one-on-one networking sessions, learn from 100 private company presentations, and virtually attend investor panels/startup bootcamp sessions with industry experts. Learn more and register here. […]
On June 16, Governor Herbert released Volume IV of the Utah Leads Together plan, which presents Utah’s economic recovery and revitalization plan, using a 100, 250, and 500-day time horizon. Volumes I, II, and III of the Utah Leads Together plan presented economic phases, color-coded health guidance, instructions for high-risk individuals, recommendations from Utah’s multi-cultural […]